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Several organophosphate and organochlorine compounds, including pesticides commonly found in
the Great Lakes basin, have the potential to induce immunotoxicity. Because of biomagnification
and accumulation in the food chain, Great Lakes residents may inadvertently be exposed to these
compounds and thus face increased risk of immune dysfunction. In spite of the laboratory animal
data and evidence from occupational exposures that suggest immunotoxicity, there is no
definitive evidence as yet that environmental exposure to these xenobiotics poses a significant
threat to the human immune system that is sufficient to predispose residents of the Great Lakes
basin to increased disease. However, uncertainties with regard to exposure levels, predictability
of tests, suitability of the animal models, and immune reserve cannot be ruled out when making
risk assessment decisions such as this. - Environ Health Perspect 103(Suppl 9):55-61 (1995)
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Introduction
Pesticides are among the many chemicals
present in the Great Lakes basin. Four of
these pesticides, including hexachloroben-
zene (HCB), mirex, dieldrin, and dichloro-
diphenyltrichloroethane (DDT) and its
metabolites, have the potential to produce
immunotoxicity and are thus among the
11 critical environmental pollutants
identified by the International Joint
Commission (1). Although not considered
as critical pollutants, other organochlorine
and organophosphate pesticides such as
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chlordane and malathion have the poten-
tial for human exposure through the food
chain (2). In addition to the presence of
measurable residues in fish and wildlife as
well as people living in the Great Lakes
basin, the pesticides listed above have
documented immunotoxic effects in labo-
ratory animal studies. The effects range
from an increased incidence ofexperimen-
tal infection to specific effects on immune
system structure (histopathology) and
function (3-5).
Due to the persistent nature of these
compounds and biomagnification and accu-
mulation in the food chain, Great Lakes
residents who consume large amounts of
contaminated fish and wildlife may ingest
greater amounts of these compounds than
the general population. At the present time
there is no clear evidence that environmen-
tal exposure to these pesticides through
consumption of contaminated fish or
wildlife in the Great Lakes Basin poses a
threat to the human immune system.
Currently, the best source of information
concerning the potential immunotoxic
effects ofthese pesticides in humans comes
from laboratory animal studies. These
studies have shown that under defined con-
ditions these compounds can modulate the
immune system. Generally, the effects are
seen only in carefully controlled laboratory
studies using inbred or hybrid strains of
experimental animals. Furthermore, the
doses of pesticide required to modulate
the immune response are often orders of
magnitude higher than those reported for
human exposure.
A review ofpertinent laboratory animal
studies, as well as epidemiology reports of
occupational exposure to pesticides, and
potential immunotoxicity is presented.
There are data that suggest that occupa-
tional exposure to pesticides, especially in
situations where high concentrations of
material are present, can induce contact and
immediate (respiratory) sensitization. [For
recent reviews on this subject, see Edmiston
and Maddy (3), Thomas et al. (5), and
Murray and Thomas (6)]. Emphasis in this
review is placed on data concerning the
potential immunosuppressive effects ofpes-
ticides and related compounds that tend to
persist in the environment and may be par-
ticularly important under chronic exposure
conditions such as those encountered in
and around the Great Lakes Basin.
Animal Studies
Several organophosphate and organochlo-
rine compounds, including pesticides
commonly found in the Great Lakes basin,
have been shown to alter immune func-
tion in laboratory animals. Typically, labo-
ratory animal studies are conducted under
carefully controlled conditions with acute
or relatively short-term exposures at con-
centrations considerably higher than those
encountered in the environment. Consid-
erable variation exists in animal species
used and in route, duration, and level of
exposure, as well as end point examined.
In almost no case were efforts made to ver-
ify actual delivered dose. In studies involv-
ing dose-response experiments, little effort
is ever made to determine a lowest observ-
able effect level (LOEL). In some cases,
increased susceptibility to an infectious
agent and alterations in immune-function
parameters were reported; in others, only
changes in immune function were exam-
ined. In spite of these experimental
uncertainties, it is clear that many organo-
chlorine and organophosphate compounds,
including pesticides, are capable of modu-
lating the immune system. Since some of
these materials have the potential to persist
in the environment, they are particularly
important from a health hazard perspec-
tive under chronic exposure conditions
such as those encountered by individuals
consuming fish from the Great Lakes. [For
a comprehensive review of the literature
on pesticide immunotoxicity, see Thomas
et al. (5), Luster et al. (7), Newcombe and
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Esa (8), and Sharma (9)]. Briefreviews of
relevant laboratory animal studies are
presented below.
Organophosphorus Compounds
Organophosphate pesticides were first
reported as immunotoxicants in the early
1970s by Ercegovich (10) and Street and
Sharma (11). The latter study reported
thymic atrophy and reductions in splenic
germinal centers in rabbits following expo-
sure to 1.5 mg/kg/day of malathion.
Reductions in protective responses in mice
to the Gram-negative bacterium Salmonella
typhimurium were reported following
malathion exposure (12). Studies by Casale
et al. (13) reported suppression ofprimary
humoral immune responses to a T-cell-
dependent antigen in rodents treated orally
with cholinergic doses of parathion (16
mg/kg), malathion (720 mg/kg), or
dimethyl dichlorovinyl phosphate (DDVP;
120 mg/kg). Suppression was absent at
noncholinergic doses, suggesting that stress
may have played a role. Casale and col-
leagues (14) compared several organophos-
phate compounds for their ability to
inhibit human serum complement-medi-
ated lysis ofsheep red blood cells (SRBC).
Although dose-dependent inhibition of
complement activitywas noted, potencies of
these compounds to inhibit acetyl-
cholinesterase activity did not correlate with
classical complement inactivation. The
authors concluded that the risk ofcomple-
ment inactivation leading to increased inci-
dence of infection is small in workers
occupationally exposed to anticholinesterase
compounds. An immunosuppressive mech-
anism involving cholinergic stimulation is
thought by some to be unlikely, given the
fact that cholinergic agonists fail to suppress
the immune system in vivo (15-17).
Extensive studies by Rodgers and col-
leagues (18-23) have focused on defining
the impact ofthe trialkylphosphorothioate
contaminant 0,O,S-trimethyl phospho-
rothioate (OOS-TMP) on the rodent
immune system. This compound is formed
as an impurity during the manufacture and
storage of certain organophosphate pesti-
cides such as malathion and fenitrothion.
Briefly, dose-dependent suppression of
both humoral immunity and inability to
generate cytotoxic T-lymphocytes was
noted. Further, decreased antigen presenta-
tion and Ia antigen expression was noted in
splenic macrophages from OOS-TMP
treated mice (18-23). The dose levels with
which effects were seen ranged from 0.5 to
10 mg/kg. Rats treated orally with a single
dose of 20 mg/kg OOS-TMP exhibited
altered macrophage cytotoxicity and
esterase activity, which may contribute to
the pathogenesis oflung injury seen in rats
treated with these compounds (24).
Hinton et al. (25) illustrated that toxic-
ity observed in health effect studies ofthese
compounds is often due to technical-grade
contaminants. No statistically significant
suppression of immune status (antibody
titers, serum immunoglobulins, immuno-
histopathology) was noted in Sprague-
Dawley rats receiving pure triphenyl
phosphate (TPP) at doses up to 10,000
ppm in the diet for 120 days. Although the
data suggest that TPP has no effect on
innate or adoptive immunity, the extremely
small numbers ofanimals/dose/end point
(i.e., two to three rats per point for anti-
body titers) limit the statistical power of
this study.
Hexachiorobenzene
Hexachlorobenzene (HCB) is one of the
most persistent and ubiquitous chemicals
in the environment. It is no longer manu-
factured in Canada or the United States for
use as a fungicide, although it is generated
in significant quantities as a by-product
(26). The acute toxicity of HCB is rela-
tively low in laboratory animals, and the
oral LD50 (lethal dose, 50%) for rats is
greater than 3000 mg/kg (27).
Animal studies have demonstrated
species-specific effects of HCB on the
immune system. Based upon studies by
Loose et al. (28), increased susceptibility to
infection and increased sensitivity to endo-
toxin challenge were noted in mice fed
approximately 30 mg HCB/kg/day. Unfor-
tunately, a no observable adverse effect level
(NOAEL) could not be estimated from
these studies since single concentrations of
HCB were administered. Effects on the gen-
eration ofhumoral immunity are less clear
cut (29). Barnett et al. (30) reported that in
the absence ofchanges in splenic B- and T-
cell mitogenesis, antigen-specific delayed-
type hypersensitivity and mixed lymphocyte
culture responses were suppressed in mice
exposed perinatally to up to 5 mg/kg HCB.
On the other hand, combined prenatal and
postnatal exposure of rats to as little as
4 mg/kg HCB significantly increased
immunoglobulins M and G (IgM, IgG)
antibody titers to tetanus toxoid as well as
delayed hypersensitivity to ovalbumin in a
dose-dependent manner relative to controls
(31). In these studies at dose levels that
appear to stimulate the-immune system, no
changes in host defense against experimental
infection with Trichinella spiralis was seen.
Recent studies have confirmed and extended
those earlier observations by demonstrating
increases in IgM serum and autoantibody
levels in rats fed approximately 18 mg
HCB/kg per day for 13 weeks. Further-
more, biotransformation studies suggest that
HCB-induced porphyria is not involved as a
mechanism ofimmune modulation by this
compound (32).
Short-term exposure to 35 mg/m3
HCB aerosols for 1 or 4 days significantly
reduced the capacity of alveolar macro-
phages to phagocytize radiolabeled red cells
as well as viable Klebsiellapneumoniae bac-
teria, suggesting impaired pulmonary host
defense (33). Lymphoproliferative responses
to T- and B-cell mitogens in these studies
in the lung-associated and mesenteric
lymph nodes exhibited differential. effects
depending upon location and duration of
exposure. In other studies, evidence of
reduced pulmonary natural killer cell activ-
ity was observed in rats following oral
exposure to 150 mg/kg HCB in the diet
for 6 weeks (34); unfortunately, a NOAEL
could not be determined from this study.
Proliferation oflymph node, high endothe-
lial venules following HCB exposure noted
by Kitchin et al. (35), as well as Vos et al.
(36), in rats at prenatal and postnatal
HCB doses of 50 mg/kg/day may alter T-
and B-lymphocyte trafficking and explain
these differential effects. Hyperplasia of
gut-associated lymphoid tissues was also
noted in dogs administered as little as 1
mg/kg/day (37), providing further histo-
logical evidence for an effect of HCB on
the immune system.
Mkiex
Mirex is a cyclodiene contact insecticide,
although it has had several other applica-
tions. Its use in Canada has been banned
since 1978. It is one of the most stable
chemicals known, but it does slowly break
down to photomirex (8-monohydromirex),
a toxic chemical that contains one less
chlorine atom than mirex.
Single doses of mirex are moderately
acutely toxic in laboratory animals. The
acute oral LD50 ofmirex in rats is 600 to
700 mg/kg. Mirex causes several effects in
laboratoryanimals, induding morphological
changes in the liver (0.05 mg/kg/day), feto-
toxicity (1-2 mg/kg/day), and carcinogenic-
ity (5-10 mg/kg/day) (38). A no observable
effect level (NOEL) for the immune system
can be estimated at 40 mg/kg in chickens
following chronic (5-week) dietary exposure
to thepesticide (39).
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DieldrinandAldrin
Dieldrin and aldrin are persistent chlorinated
hydrocarbon insecticides that were used in
Canada and the United States for control of
soil insects and mosquitos. Both were man-
ufactured on a commercial scale between
1950 and 1990. Most uses ofaldrin and
dieldrin were banned in the United States in
1975. In Canada, all food uses for dieldrin
were prohibited in 1978 and only limited
applications are now permitted (1).
Aldrin is rapidly metabolized to dield-
rin in plants, animals, and humans. The
modes of action of both compounds,
including acute and chronic toxicity, are
nearly identical. Single doses of dieldrin
have a high acute toxicity in laboratory ani-
mals, and the acute oral LD50 in rats is
approximately 50 mg/kg (40). The overall
NOAEL for chronic toxicity in rodents is
approximately 1 mg/kg/day (40). Relative
to the NOEL, the immune system appears
to be fairly resistant to the effects of this
pesticide. Inhibition of the ability of
murine macrophages to restrict intracellu-
lar viral replication ofmouse hepatitis virus
3 (MHV3) was seen in mice receiving a
single ip injection of36 mg/kg dieldrin, a
very high acute dose (41). In related
studies, impairment ofmacrophage phago-
cytosis, as well as suppression ofantibody
responses to both T-dependent and T-inde-
pendent antigens, was also observed, albeit
at similar high acute ip doses (42,43). The
investigators suggested that the former
changes contribute to increased susceptibil-
ity of C57B1/6 mice to challenge with
MHV3 in vivo seen in earlier studies (44).
In spite of these effects, the biological
significance ofthese observations in light of
the comparatively low toxicity ofdieldrin
can be questioned.
In continued studies, impairment of
T-cell-mediated graft-versus-host reactions
was seen in recipient mice receiving allo-
geneic lymphoid cell suspensions from
dieldrin-treated mice (45). Hugo et al.
(45) ruled out changes in lymphocyte sub-
sets, cytotoxicity, and inhibition ofT-cell
proliferation potential as mechanisms.
Since they did not fully characterize the
donor cell population, the contribution of
macrophages to this effect cannot be dis-
counted. Treatment ofC57B1/6 mice with
mixtures ofdieldrin, malathion, and car-
bofuran did not result in synergy or additiv-
ity ofeffects attributed to single compound
exposures (46). As to the LD50 value above,
the doses used in the above studies are rela-
tively high. Furthermore, the LOEL could
not be estimated from these studies.
Dichlorodiphenyltrichloroethane
Dichlorodiphenyltrichloroethane (DDT)
was developed in the late 1930s and it was
used extensively as a broad-spectrum con-
tact organochlorine insecticide. Its use
peaked in the early 1960s, with U.S pro-
duction at 176 million pounds in 1963. In
1973, DDT was banned in the United
States except for essential public health
purposes. In the early 1970s, most uses of
DDT were banned in Canada, but the last
remaining product registration was not dis-
continued until 1989.
Although DDT is relatively stable, it
undergoes a relatively complex series of
biological degradative changes. The most
important ofthese is dehydrochlorination
to dichlorodiphenyldichloroethylene
(DDE). DDE is more lipid soluble and, as
a result, is much less toxic to mammals
than DDT. Like the parent compound,
DDE is retained in tissues for long periods
oftime.
The acute oral LD50 for DDT in rats is
approximately 100 mg/kg. In contrast to
the other priority pesticides found in the
Great Lakes Basin, numerous studies have
been conducted on the effect of DDT on
the immune system oflaboratory animals
(39,47-50). In general, the immune sys-
tem is not a sensitive target organ for toxic-
ity. Differences in species used, dose,
duration, routes ofexposure, and parame-
ters evaluated make it difficult to estimate a
LOEL for the immune system. However,
the lowest in vivo immunosuppressive
effects of DDT were based upon histo-
pathological changes in lymphoid organs in
rabbits fed the equivalent of 0.18 mg/kg
DDT/dayfor up to 8 weeks (11).
Acute DDT poisoning in humans is
rare, considering its widespread use. A sin-
gle oral dose of 10 mg/kg produces toxicity
in humans. There is no evidence of any
adverse long-term effects resulting from
small daily doses of DDT and no conclu-
sive evidence that DDT is immunosup-
pressive in humans inadvertently exposed
through the food chain. Recent reports
(51) have cited an association between
DDT exposure and appearance ofbreast
cancer, but the relationship ofthis observa-
tion to changes in tumor surveillance
mechanisms has not been established.
Chlordane
Chlordane has had a wide variety of
applications since its development as an
insecticide in the mid-1940s. It was heav-
ily used without restriction until the sole
U.S. manufacturer voluntarily stopped
production in 1988. Chlordane is absorbed
and retained in lipid-containing tissues fol-
lowing any route of exposure; therefore,
the potential exists for immunotoxicity.
Laboratory animal studies have suggested
that this compound adversely affects the
immune system, especially in the fetus. In
1982, Spyker-Kranmer et al. (52) reported
that the offspring of mice treated perina-
tally with chlordane exhibited suppressed
cell-mediated immunity (CMI) compared
to controls. In the absence of effects on
adult animals (53), chlordane appears to
exert immunotoxic effects in utero. Menna
et al. (54) demonstrated that, compared to
controls, chlordane-exposed offspring are
capable ofwithstanding a higher challenge
dose of influenza virus in the absence of
effects on viral replication in vivo (55).
Diminution ofviral specific delayed-type
hypersensitivity responses in the absence of
changes in T-cell blastogenesis at maternal
chlordane dose levels of4 mg/kg/day may
have minimized infectious pathogenesis
and contributed to increased survival (56).
In further studies, persistent suppression of
adult bone marrow colony formation was
noted in perinatally treated animals (57)
with females exhibiting greater sensitivity
(58). Furthermore, recent studies suggest
that 8 mg/kg maternal doses of chlordane
differentially introduce defects in macro-
phage biochemical mechanisms associated
with tumor cell killing in offspring (59).
In vitro studies suggest that chlordane
impairs early activational events in anti-
body synthesis, albeit at relatively high
concentrations ofup to 10 fM (60).
Unlike other organochlorine com-
pounds, the above studies suggest that peri-
natal exposure to chlordane induces long
lasting and subtle effects on immune func-
tion. The in vivo perinatal exposure model
used in many of the above studies, how-
ever, achieves a total maternal chlordane
dose that approaches 3 mg, an amount that
may not be environmentally realistic with
regard to human exposure potential.
Human Studies
In the case of occupational pesticide
exposure, few examples have been reported
for which a direct correlation of immuno-
toxic effects in man and experimental
animals can be made. Studies based on
data derived from company and municipal
death records suggest an association
between occupational exposure to pesti-
cides in grain mills, for example, and
higher incidence of neoplasms in the
hemopoietic and lymphatic tissue than
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observed in other tissues. Similarly, increases
in the incidence ofleukemia and myeloid
leukemia occurred among pesticide workers
in Florida (61). Pearce et al. (62) suggested
that pesticides act additively or synergisti-
cally with other chemical agents and con-
cluded that agricultural workers have an
increased risk of multiple myeloma, not
because ofany obvious patterns ofpesticide
use but perhaps because ofother chemicals
used in their industry. Recently a cohort
mortality study among more than 5000
chemical-manufacturing workers showed
increased mortality due to pancreatic cancer
(63). Among subjects with a mean exposure
to DDT of47 months, the authors claim
that the cancer risk was 7.4 times greater
than amongsubjects with no exposure.
A recent review and metaanalysis ofepi-
demiologic studies ofhuman pesticide expo-
sure performed from 1975 to 1991 revealed
no significant decrease in life expectancy or
increase in cancer incidence as a result of
exposure (64). However, the authors noted
an increased risk ofmyeloproliferative disor-
ders associated with exposure among manu-
facturers, applicators and farmers. Marconi
and Fait (64) caution that other etiological
agents (e.g., viruses) that may be responsible
cannot be ruled out.
Although there is evidence that pesti-
cides affect certain functions ofthe immune
and hematopoietic systems that may pre-
dispose to neoplasia, it remains difficult to
relate these changes to clear-cut adverse
health risks. For example, even though
morphological changes in blood were
observed in special occupational conditions
such as pesticide application within green-
houses where high concentrations ofpesti-
cide were present, there was no indication
of altered immune status (65). However,
in a study ofpesticide workers exposed to
combinations offour widely used organo-
phosphate and organochlorine pesticides
(malathion, parathion, DDT, and hexa-
chlorocyclohexane), 73% showed signs of
toxicity, including altered levels ofserum
immunoglobulin levels (66). Increases in
serum IgG but decreases in serum IgM and
complement C3 were reported in a study
of 51 men exposed to chlorinated pesti-
cides as compared to a 28-man control
group. Immune complexes were suggested
as a possible significant factor in occupa-
tional diseases (67). In each ofthese stud-
ies, a direct association with a change in
immune status was absent. Some in vitro
studies complement these findings by
showing that either paraoxon or malathion
reduces both erythrocyte and granulocyte
stem-cell colonyformation and thus support
the principle that pesticides affect stem cell
growth (68).
Although it is well documented that
exposure to organophosphorus compounds
alters human monocyte carboxylesterase
activity (69-71), the biological significance
ofthis effect is still unclear. The concentra-
tions of organophosphorus compounds
causing 50% inhibition of monocyte
esterase activityhave been determined to be
in the 1 to 10 pM range (72). Although no
measurements were taken, Newcombe and
Esa (8) concluded that exposed workers
presenting decreased monocyte esterase
activity may have circulating concentrations
of organophosphorus compounds in the
same concentration range. Apossible mech-
anism for inhibition of monocyte-non-
specific esterases was suggested by Paxman
et al. (73). Adherent human monocytes
(not lymphocytes or neutrophils) released
phenol upon exposure to radiolabeled
(TPP). The cellular degradation ofTPP
was inhibited by diisopropylfluorophos-
phate (DFP), an esterase inhibitor.
Catechol, hydroquinone, and biphenyls
were also produced. It was concluded that
TPP inactivates nonspecific esterase by
phosphorylation after release ofphenol.
An early report by Lee et al. (74)
demonstrated that for malathion, the
in vitro IC50 (inhibitory concentration,
50%) for T-lymphocyte responses to phy-
tohemaglutin was 35 pM. Furthermore, a
10-pM concentration ofmethylparathion
in culture significantly reduced neutrophil
chemotaxis. Esa et al. (72) reported studies
on the modulation of CMI responses and
monocyte accessory cell function following
in vitro exposure ofhuman cells to a num-
ber oforganophosphate compounds. Ofthe
four compounds tested, dose-related
suppression of antigen-induced human
lymphocyte proliferation was seen only fol-
lowing pretreatment with tetra-o-cre-
sylpiperazinyl diphosphoamidate (TCPD)
for 16 hr. Although dose related, this effect
was not striking. Ifthe incubation time is
reduced from 16 to 6 hr, the effect is not
apparent at the same concentrations
(10 pM) as above. Partial restoration ofcell
cultures containing normal lymphocytes
and TCPD-treated monocytes that allows
a response to antigen suggests that the
defect resides in the monocyte. The fact
that restoration was only 70% ofcontrol
implies that other factors may be involved.
Antigen presentation studies with mono-
cytes indicate that there may b.e a delay in
the kinetics for antigen processing and
presentation at chemical concentrations as
low as 1 pM. These data may correlate with
those of Paxman et al. (75), suggesting
that organophosphorus compounds induce
down regulation of monocyte surface
HLA-DR antigen expression, a function
critical to normal immune responsiveness.
Although considerable information is
known about the molecular mechanisms of
esterase inhibition and functional immune
impairment by organophosphorus com-
pounds, there is no convincing evidence
that humans occupationally exposed to
these materials have higher incidences of
infection or disease (69,70). Hermanowicz
and Kossman (76) examined neutrophil
function and prevalence of respiratory
infections in workers occupationally
exposed to organophosphate pesticides
compared to controls. Inhibition of serum
and red blood cell cholinesterase correlated
with degree ofexposure. In contrast to the
studies described above, increased overall
incidence of respiratory infection was
observed in exposed workers compared to
controls. In addition, the incidence of
recurrent infection was positively corre-
lated with length ofexposure. Impairment
of neutrophil chemotaxis was also
observed; however, in workers exhibiting
increased morbidity, neutrophil function
was similar to those that were healthy. It
was concluded that inhibition of host
defense was not due to impairment ofneu-
trophil function but may have resulted
from other nonspecific effects on the lung.
Summary and Conclusions
In summary, it is clear that under carefully
controlled laboratory conditions pesticides
and related compounds associated with the
Great Lakes basin are capable ofmodulat-
ing the immune system of experimental
animals. However, in assessing potential
risks to the immune system ofGreat Lakes
residents from environmental exposure to
these compounds, problems include deter-
mining the exposure variables related to a
particular compound, identifying the appro-
priate immunologic end points for evalua-
tion, and interpreting the data gathered as a
result ofthese evaluations. Subtle perturba-
tions in immune function following expo-
sure to environmental chemicals may not,
in every instance, result in a relevant health
effect. Alternatively, subtle changes in cer-
tain immune functions could conceivably
increase the likelihood ofadverse immune-
related health effects only during the brief
period when these effects are present, or
these changes may result in minor health
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changes unlikely to be disclosed in an
epidemiology study. Current epidemiologic
evidence, however, concerning some ofthe
more toxic environmental chemicals does
not provide support for a strong link
between subtle immunologic perturbations
and biologically relevant changes in resis-
tance to disease, although it cannot be
ruled out that problems associated with
studies of this nature have precluded the
detection of evidence for this link. The
usefulness ofepidemiology studies in link-
ing environmental exposure to pesticides in
the Great Lakes basin with altered immune
status and subsequent changes in resistance
to disease is not clear cut at present.
Variability among the population with
respect to immune status, the inability to
objectively measure the immune function,
and the confounding factors involved in
interpretation of these measures decrease
the probability of using broad-based epi-
demiologic studies to identify xenobiotics
that are responsible for causing immuno-
logic injury. Standardized methods of
assessing human immune function are now
widely available and need to be used in the
present context to better establish baseline
values for important immunologic end
points for future use in well-designed epi-
demiology studies. With this information,
selected epidemiologic studies, either in the
workplace or shortly after a well-docu-
mented exposure to a toxic compound,
would have a better chance ofidentifying
xenobiotics that either produce relevant
immunomodulation or are good immuno-
gens, resulting in the development of
hypersensitivity responses.
Human immunotoxicity risk assess-
ment is receiving attention from the sci-
entific community (77). The immune
system represents a complex target for
chemical interaction. Furthermore, since
the understanding of interactions between
toxic chemicals and the immune system is
still developing, data must be interpreted
cautiously. In terms ofrisk assessment, the
immune system can, in many respects, be
approached similarly to other target organs.
Along those lines, demonstrating dose-re-
sponse relationships is an important crite-
rion. The dose-response curve provides the
basis for determining no-effect and low-
effect levels. To this end, laboratory animal
safety studies to investigate immunotoxic-
ity ofpesticides or otherxenobiotics should
be designed to quantify exposure or dose as
well as define a NOEL for the immune
system. Without this information, mean-
ingful risk extrapolation to humans cannot
be made.
In general, laboratory studies docu-
menting pesticide immunotoxicity have
been performed using single chemicals in
young adult animals with normal host
defense mechanisms. Evidence to date
suggests that individual pesticides at con-
centrations found in the Great Lakes envi-
ronment do not pose a significant risk to
the immune system ofhumans. However,
in reality, single chemical exposures are
not the rule. Chemical mixture studies in
rodents (78) have suggested that in the
absence of overt toxicity, rapidly prolifer-
ating cells of the immune system may be
targeted. Although the authors caution
that this represents a worst case scenario,
the potential for synergy or additivity with
regard to immune system effects cannot be
ignored. As to potential immune damage
in humans resulting from pesticide expo-
sure, certain selected populations may be
at a greater risk than the general public.
These groups include pesticide manufac-
turers and applicators, residents ofneigh-
borhoods adjoining intensive pesticide use
areas, atopic or asthmatic individuals pre-
disposed to developing hypersensitivity,
genetically predisposed individuals,
patients on drug therapy, immunologi-
cally compromised individuals, and the
young and aged. Future research should
include examination ofthese selected pop-
ulations to demonstrate if these cohorts
are especially at risk.
Although no substantial evidence exists
yet that exposure to pesticides, either in the
workplace or through contact in the envi-
ronment, induces significant immune dys-
function in humans, assessment of risk
should take into account the following
uncertainties. Exposure levels required to
induce immune change in laboratory ani-
mals may not yet be achieved in humans
under the present conditions of environ-
mental exposure. Based upon the effects
observed in rodents, the diagnostic tests
now routinely performed in humans may
not detect immune changes if they do
exist. Adverse health effects associated with
subclinical immune dysfunction in humans
may be subtle and thus difficult to quanti-
tate (e.g., increased incidence or severity of
common infections). Diseases associated
with immune dysfunction can become
detectable only after a long latency or after
more severe immunomodulation and, as a
result, may be difficult to detect initially.
Although similarities exist between the
immune systems of rodents and humans,
subtle differences in detoxification mecha-
nisms and adaptation processes may render
humans more resistant to pesticide-
induced immunologic damage. The nor-
mal immune response in humans is quite
heterogeneous, making it difficult to dis-
cern a subtle adverse effect without a large
experimental cohort.
In conclusion, it is clear from the litera-
ture that levels of organochlorine or
organophosphate pesticides required to
modulate the immune system of experi-
mental animals are considerably higher
than levels in humans from estimated
dietary exposure. Furthermore, around the
Great Lakes, the levels of these pesticides
entering the food chain are, for the most
part, continuing to decrease. Therefore, the
risk to the human immune system from
environmental or dietary exposure to these
xenobiotics is probably quite low.
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